16.75
price up icon4.10%   0.66
after-market Handel nachbörslich: 16.62 -0.13 -0.78%
loading

Finanzdaten der Ars Pharmaceuticals Inc-Aktie (SPRY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - 0.01 0.02
Operating Expenses
29.00%
13.19
10.23 17.98 20.61 18.73
Operating Income/Loss
29.00%
-13.19
-10.23 -17.98 -20.60 -18.71
Income/Loss From Continuing Operations Before Tax
-10.29
- -14.87 0.01 0.02
Income/Loss From Continuing Operations After Tax
43.58%
-10.29
-7.168 -14.87 -17.37 -14.96
Net Income/Loss
43.58%
-10.29
-7.168 -14.87 -17.37 -14.96
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
31,503%
96.49
0.3053 95.58 94.91 94.23
Diluted Average Shares
31,503%
96.49
0.3053 95.58 94.91 94.23
Basic Earnings Per Share
57.14%
-0.11
-0.07 -0.16 -0.18 -0.16
Diluted Earnings Per Share
57.14%
-0.11
-0.07 -0.16 -0.18 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):